Which ASX 200 share has quietly risen by almost 115% in 2023?

And it's resetting its 52-week high again today.

| More on:
Male building supervisor wearing high vis vest and hard hat stands and smiles with his arms crossed at a building site

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At the start of the year, plenty of brokers were recommending an ASX 200 share that has since risen by 114.3% and has just hit yet another 52-week high today.

That ASX 200 share is building materials supplier James Hardie Industries plc (ASX: JHX).

In early trading on Wednesday, the James Hardie share price is up 2.1% to $55.88. Meantime, the S&P/ASX 200 Index (ASX: XJO) is up 0.77% to 7,559 points.

In late 2022 and early 2023, a bunch of brokers including QVG Capital, L1 Capital, and Goldman Sachs were backing the stock to outperform in 2023.

They argued that the ASX 200 building materials share had been oversold due to the Australian and US housing market downturns in 2022, but remained attractive for long-term investing.

When James Hardie lowered its FY23 earnings guidance in February, top broker Citi said it was a "buying event" for investors.

If you'd listened to all this advice and put $10,000 into James Hardie on the first day of trading this year — when it closed at $26.12 per share — your holdings would now be worth a cool $21,368.

And James Hardie appears set to remain on a positive trajectory.

The ASX 200 share hit a new 52-week high in early trading this morning, reaching $56.05 apiece.

What do the experts think about this ASX 200 share today?

The consensus rating among the analysts on CommSec today is a moderate buy. The rating was reduced from a Strong Buy just a fortnight ago.

The latest analysis from Goldman Sachs describes the business as "outperforming the market without sacrificing margin". The broker has a buy rating on the stock and a 12-month target price of $54.45.

Goldman Sachs commented:

We increase our FY24e estimates by 14%, largely driven by an increase in expected North America earnings. This reflects a better volume outlook with associated operating leverage.

Based on guidance, the 3Q base was substantially better than we had forecast, and normal seasonality would suggest ~MSD+ sequential growth into the 4Q.

Our FY25/26 estimates have increased ~12%. As a result of our forecast changes, partially offset by a lower reference market multiple our TP increases to $54.45. Retain Buy.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bronwyn Allen has positions in James Hardie Industries Plc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »